Since the GPER has been associated with development of NSCLC, a selective GPER inhibitor, for example, the G15 has been linked to inhibition of this type of cancer development by reversing E2-induced cell proliferation [134]. Here, GPER1 is linked to non-small cell lung carcinoma.